Description

As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers in drop down menu in audio player above) 

• Baxter
• Samsung Biologics
• Lotte Biologics
• Fujifilm Diosynth Biotechnologies
• Lonza 
• Cambrex
• Expansions in peptides, oligonucleotides 
• Bachem
• Agilent Technologies
• WuXi STA
• CordenPharma
• Ajinomoto
• Bain’s acquisition of F.I.S.
• eureKING
• New CDMOs enter the market 
• Bridgewest Group 
• SynCrest 
• NewBiologix 
• Ascend Gene & Cell Therapies 

Podcast Sponsor: Vetter Pharma International GmbH

Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show  

Support the show